Ihr Browser kann das Objekt leider nicht anzeigen!
Lead WP2b:    
Rolf Bass, University of Basel, ECPM, Switzerland
.
Co-Lead:
Cecilia Potez, AstraZeneca, UK


 

WP 2 b.: „European Master of Pharmaceutical Regulatory Affairs“ EMPRA


Objectives
  • Make use and adapt MAS (Master or Advanced Studie) of Drug Development Sciences, MDDS, to a MAS of Pharmaceutcial Regulatory Affairs (EMPRA).